within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A08A_AntiobesityPreparationsExclDietProducts.A08AA09_Mefenorex;
model Mefenorex 
   extends Pharmacolibrary.Drugs.ATC.A.A08AA09;

  annotation(Documentation(
    info ="<html><body><p>Mefenorex is an amphetamine derivative that was used as an anorectic agent for weight loss management in the treatment of obesity. Due to concerns about amphetamine-like side effects and potential for abuse, mefenorex has been withdrawn from the market and is not approved for use in most countries today.</p><h4>Pharmacokinetics</h4><p>No dedicated peer-reviewed pharmacokinetic studies in humans could be identified. Pharmacokinetic parameters are estimated based on structurally similar amphetamine derivatives with oral administration in healthy adults.</p><h4>References</h4><ol><li><p>Rendić, S, et al., &amp; Medić-Sarić, M (1994). Urinary excretion and metabolism of orally administered mefenorex. <i>European journal of drug metabolism and pharmacokinetics</i> 19(2) 107–117. DOI:<a href=&quot;https://doi.org/10.1007/BF03188831&quot;>10.1007/BF03188831</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8001591/&quot;>https://pubmed.ncbi.nlm.nih.gov/8001591</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Mefenorex;
